Your Fat Has a Storage Limit @BarbellMedicine
Your Fat Has a Storage Limit  @BarbellMedicine
Uploaded August 2026 | Updated November 2026, 3 days ago
In 2004 a surgeon removed about ten kilograms of fat from fifteen women and measured everything that mattered. Nothing improved. Four years later, it still hadn't.






That result should have ended an argument about body fat. Instead the argument got more specific, and the version you've heard most recently is that visceral fat, the fat around your organs, is the dangerous kind. I've said a version of that myself on this show, and in this episode I expand upon it.






This one starts from the beginning: what your fat is actually for, what insulin is, and what insulin resistance means, in plain terms and assuming nothing. Then four experiments that all point the same direction. Fat removed surgically, and the disease doesn't follow. People born with no fat tissue at all, who get the entire disease anyway. A hormone that reversed a 48% fatty liver without adding a gram of fat. And a diabetes drug that made people heavier and healthier at the same time.






The second half is practical. What a fatty liver actually does over twenty years, what BMI can and can't do, why the Lancet Commission changed the definition of obesity in 2025, and the exact order of tests I'd use, including the TyG index, FIB-4, and where each one stops working.






Part one of two. Next episode is about muscle.






Timestamps:






00:00 The Liposuction Experiment


02:06 The Visceral Fat Correction


05:47 What Fat Is For


08:14 The Carb Insulin Model


10:51 Filling The Garage


14:35 Taking The Fat Out


17:57 Born Without Fat Tissue


22:52 Heavier And Healthier


25:05 Neptune And Vulcan


29:57 The Patient Nobody Checked


33:59 What Every Ruler Missed


36:00 What To Actually Order


40:29 What Obesity Actually Is






Resources:


Vital 5 (TyG , waist to height, etc. discussion):






barbellmedicine.com/vital-5-action-plan


New Barbell Medicine Hybrid 5K and 10K Run + Lift Programs (barbellmedicine.com/shop/training-templates/endurance/hybrid-5k-10k/)


Barbell Medicine coaching and templates: barbellmedicine.com


Plus podcast subscription:






barbellmedicine.com/shop/subscriptions/plus-podcast-subscription






Barbell Medicine Premium: barbellmedicine.com/shop/subscriptions/barbell-medicine-premium






Signal (now shipping): barbellmedicine.com/shop/learning/signal





1. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350(25):2549-2557. doi:10.1056/NEJMoa033179
2. Mohammed BS, Cohen S, Reeds D, Young VL, Klein S. Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease. Obesity (Silver Spring). 2008;16(12):2648-2651. doi:10.1038/oby.2008.418
3. Sommer I, Teufer B, Szelag M, et al. The performance of anthropometric tools to determine obesity: a systematic review and meta-analysis. Sci Rep. 2020;10(1):12699. doi:10.1038/s41598-020-69498-7
4. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343-1351. doi:10.1172/JCI23621
5. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453(7196):783-787. doi:10.1038/nature06902
6. Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010;139(2):448-455. doi:10.1053/j.gastro.2010.04.056
7. Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220-1234. doi:10.1056/NEJMra025261
8. Al Yaarubi S, Alsagheir A, Al Shidhani A, et al. Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa. Orphanet J Rare Dis. 2024;19(1):118. doi:10.1186/s13023-024-03084-2
9. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109(10):1345-1350. doi:10.1172/JCI200215001
10. Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2002;87(6):2784-2791. doi:10.1210/jcem.87.6.8567
11. Cusi K, Orsak B, Bril F, et al. Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial. Ann Intern Med. 2016;165(5):305-315. doi:10.7326/M15-1774
12. Taylor R, Barnes AC, Hollingsworth KG, et al. Aetiology of type 2 diabetes in people with a 'normal' body mass index: testing the personal fat threshold hypothesis. Clin Sci (Lond). 2023;137(16):1333-1346. doi:10.1042/CS20230586
...
Your Fat Has a Storage LimitCan Training Lower Testosterone? Yes, and Most Don’t See It ComingAn FDA panel voted no. So they convened a second panel.Is Creatine Causing Your Shin Pain? +Splitting Training, Endometriosis for Lifters | Direct Line MayDoes menopause crash your metabolism?Does Cooking Change the Calories in Your Food?Iron deficiency, not low TThe Origin Story of Menopause as a DiseaseMenopause Part 3: Body Composition, Bone, Brain, & the Fitness Changes (The Data vs the Influencers)The ultra-processed food studyTested vs untested powerlifters: the dataMHT, Testosterone and the “Menopause Needs a Special Program
Barbell Medicine |

Your Fat Has a Storage Limit

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER